Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:affiliatedWith |
Erythromycin family
|
| gptkbp:ATCCode |
gptkb:J01FA01
|
| gptkbp:CASNumber |
42346-50-3
|
| gptkbp:chemical_compound |
C37H67NO13
|
| gptkbp:discoveredIn |
gptkb:Streptomyces_erythreus
|
| gptkbp:hasSMILES |
CC[C@H]1C[C@@H]([C@H]([C@@H](O1)OC2C(C(C(C(O2)N(C)C)O)O)O)O)OC(=O)[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C)O)O)C
|
| https://www.w3.org/2000/01/rdf-schema#label |
Erythromycin D
|
| gptkbp:IUPACName |
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-β-D-xylo-hexopyranosyl)oxy]oxacyclotetradecane-2,10-dione
|
| gptkbp:mechanismOfAction |
inhibits bacterial protein synthesis
|
| gptkbp:molecularWeight |
733.9 g/mol
|
| gptkbp:PubChem_CID |
6436036
|
| gptkbp:relatedTo |
gptkb:Erythromycin
|
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Erythromycin
|
| gptkbp:bfsLayer |
5
|